Skip to main content Back to Top
Advertisement

12/5/2019

Enoxaparin Sodium Injection

Products Affected - Description

    • Lovenox injection, Sanofi-Aventis, 100 mg/ 1 mL, 3 mL multiple dose vial, 1 count, NDC 00075-0626-03
    • Lovenox injection, Sanofi-Aventis, 120 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00075-2912-01

Reason for the Shortage

    • Amphastar has enoxaparin available.
    • Apotex launched enoxaparin in early-2019.
    • Fresenius Kabi did not provide a reason for the shortage. Fresenius Kabi updated NDC numbers of the 80 mg and 100 mg prefilled syringes in October 2019.
    • Sandoz discontinued enoxaparin presentations in mid-2018 due to a supplier issue.
    • Sanofi-Aventis did not provide a reason for the shortage.
    • Teva did not provide a reason for the shortage.
    • Winthrop did not provide a reason for the shortage.

Available Products

    • Lovenox injection, Sanofi-Aventis, 100 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00075-0623-00
    • Lovenox injection, Sanofi-Aventis, 150 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00075-2915-01
    • Lovenox injection, Sanofi-Aventis, 30 mg/ 0.3 mL, 0.3 mL prefilled syringe, 10 count, NDC 00075-0624-30
    • Lovenox injection, Sanofi-Aventis, 40 mg/ 0.4 mL, 0.4 mL prefilled syringe, 10 count, NDC 00075-0620-40
    • Lovenox injection, Sanofi-Aventis, 60 mg/ 0.6 mL, 0.6 mL graduated prefilled syringe, 10 count, NDC 00075-0621-60
    • Lovenox injection, Sanofi-Aventis, 80 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00075-0622-80
    • Enoxaparin sodium injection, Amphastar, 100 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00548-5605-00
    • Enoxaparin sodium injection, Amphastar, 120 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00548-5606-00
    • Enoxaparin sodium injection, Amphastar, 150 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00548-5607-00
    • Enoxaparin sodium injection, Amphastar, 30 mg/ 0.3 mL, 0.3 mL prefilled syringe, 10 count, NDC 00548-5601-00
    • Enoxaparin sodium injection, Amphastar, 40 mg/ 0.4 mL, 0.4 mL prefilled syringe, 10 count, NDC 00548-5602-00
    • Enoxaparin sodium injection, Amphastar, 60 mg/ 0.6 mL, 0.6 mL graduated prefilled syringe, 10 count, NDC 00548-5603-00
    • Enoxaparin sodium injection, Amphastar, 80 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00548-5604-00
    • Enoxaparin sodium injection, Apotex, 100 mg/ 1 mL, 1 mL prefilled syringe, 10 count, NDC 60505-0796-04
    • Enoxaparin sodium injection, Apotex, 120 mg/ 0.8 mL, 0.8 mL prefilled syringe, 10 count, NDC 60505-0795-04
    • Enoxaparin sodium injection, Apotex, 150 mg/ 1 mL, 1 mL prefilled syringe, 10 count, NDC 60505-0798-04
    • Enoxaparin sodium injection, Apotex, 30 mg/ 0.3 mL, 0.3 mL prefilled syringe, 10 count, NDC 60505-0791-04
    • Enoxaparin sodium injection, Apotex, 40 mg/ 0.4 mL, 0.4 mL prefilled syringe, 10 count, NDC 60505-0792-04
    • Enoxaparin sodium injection, Apotex, 60 mg/ 0.6 mL, 0.6 mL prefilled syringe, 10 count, NDC 60505-0793-04
    • Enoxaparin sodium injection, Apotex, 80 mg/ 0.8 mL, 0.8 mL prefilled syringe, 10 count, NDC 60505-0794-04
    • Enoxaparin sodium injection, Fresenius Kabi, 100 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 63323-0605-84
    • Enoxaparin sodium injection, Fresenius Kabi, 100 mg/ 1 mL, 3 mL multiple dose vial, 1 count, NDC 63323-0565-86
    • Enoxaparin sodium injection, Fresenius Kabi, 120 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 63323-0569-90
    • Enoxaparin sodium injection, Fresenius Kabi, 150 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 63323-0569-84
    • Enoxaparin sodium injection, Fresenius Kabi, 30 mg/ 0.3 mL, 0.3 mL prefilled syringe, 10 count, NDC 63323-0568-83
    • Enoxaparin sodium injection, Fresenius Kabi, 40 mg/ 0.4 mL, 0.4 mL prefilled syringe, 10 count, NDC 63323-0568-87
    • Enoxaparin sodium injection, Fresenius Kabi, 60 mg/ 0.6 mL, 0.6 mL graduated prefilled syringe, 10 count, NDC 63323-0568-88
    • Enoxaparin sodium injection, Fresenius Kabi, 80 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 63323-0531-90
    • Enoxaparin sodium injection, Teva, 100 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00703-8580-23
    • Enoxaparin sodium injection, Teva, 120 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00703-8610-23
    • Enoxaparin sodium injection, Teva, 150 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00703-8510-23
    • Enoxaparin sodium injection, Teva, 30 mg/ 0.3 mL, 0.3 mL prefilled syringe, 10 count, NDC 00703-8530-23
    • Enoxaparin sodium injection, Teva, 40 mg/ 0.4 mL, 0.4 mL prefilled syringe, 10 count, NDC 00703-8540-23
    • Enoxaparin sodium injection, Teva, 60 mg/ 0.6 mL, 0.6 mL graduated prefilled syringe, 10 count, NDC 00703-8560-23
    • Enoxaparin sodium injection, Teva, 80 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00703-8680-23
    • Enoxaparin sodium injection, Winthrop, 100 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00955-1010-10
    • Enoxaparin sodium injection, Winthrop, 100 mg/ 1 mL, 3 mL multiple dose vial, 1 count, NDC 00955-1016-01
    • Enoxaparin sodium injection, Winthrop, 120 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00955-1012-10
    • Enoxaparin sodium injection, Winthrop, 150 mg/ 1 mL, 1 mL graduated prefilled syringe, 10 count, NDC 00955-1015-10
    • Enoxaparin sodium injection, Winthrop, 30 mg/ 0.3 mL, 0.3 mL prefilled syringe, 10 count, NDC 00955-1003-10
    • Enoxaparin sodium injection, Winthrop, 40 mg/ 0.4 mL, 0.4 mL prefilled syringe, 10 count, NDC 00955-1004-10
    • Enoxaparin sodium injection, Winthrop, 60 mg/ 0.6 mL, 0.6 mL graduated prefilled syringe, 10 count, NDC 00955-1006-10
    • Enoxaparin sodium injection, Winthrop, 80 mg/ 0.8 mL, 0.8 mL graduated prefilled syringe, 10 count, NDC 00955-1008-10

Estimated Resupply Dates

    • Sanofi-Aventis has Lovenox 100 mg/mL 3 mL vials and the 120 mg/0.8 mL prefilled syringes on allocation.

Updated

Updated December 5, 2019 by Stephen Andrews, PharmD, BCPS, Drug Information Specialist. Created September 7, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins